Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Field Trip Health Ltd (FTRP)

Field Trip Health Ltd (FTRP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 196,489
  • Shares Outstanding, K 57,791
  • Annual Sales, $ 961 K
  • Annual Income, $ -23,118 K
  • 60-Month Beta N/A
  • Price/Sales 95.63
  • Price/Cash Flow N/A
  • Price/Book 3.15
Trade FTRP with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.34
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/15/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    Medical - Drugs

Options Overview Details

View History
  • Implied Volatility 122.40%
  • Historical Volatility 60.55%
  • IV Percentile 77%
  • IV Rank 67.37%
  • IV High 161.23% on 11/08/21
  • IV Low 42.21% on 08/27/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 11
  • Volume Avg (30-Day) 296
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 2
  • Open Int (30-Day) 1,189

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.19
  • Number of Estimates 3
  • High Estimate -0.17
  • Low Estimate -0.20
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.32 +3.16%
on 12/01/21
5.62 -39.06%
on 11/08/21
-2.00 (-36.81%)
since 11/02/21
3-Month
3.32 +3.16%
on 12/01/21
6.41 -46.57%
on 10/19/21
-1.61 (-31.91%)
since 09/02/21
52-Week
2.50 +36.99%
on 01/05/21
7.71 -55.57%
on 02/11/21
-0.17 (-4.67%)
since 12/02/20

Most Recent Stories

More News
Field Trip Health Ltd. to Participate in Upcoming Conferences in December 2021

TORONTO, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development...

FTRP-WT.TO : 0.58 (-10.77%)
FTRP : 3.39 (-0.29%)
FTRP.TO : 4.33 (-1.81%)
3 Psychedelics Stocks Wall Street Predicts Will Soar

Psychedelic substances like MDMA and psilocybin show great potential in treating patients with neurological or psychiatric problems. Therefore, drug development companies are showing an increasing interest...

MNMD : 1.8850 (-1.31%)
CYBN : 1.3800 (-3.50%)
FTRP : 3.39 (-0.29%)
Use of Ketamine for Mental Disorders Rising While New Therapies Emerge

Palm Beach, FL –November 17, 2021 – FinancialNewsMedia.com News Commentary – The uses of Ketamine for a variety of therapies are growing. An expanding number of clinics are offering ketamine infusion...

KTTA : 3.16 (-4.24%)
CMPS : 31.04 (-3.00%)
FTRP : 3.39 (-0.29%)
FTRP.TO : 4.33 (-1.81%)
CYBN : 1.3800 (-3.50%)
ATAI : 10.97 (+0.46%)
Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results and Provides Business Update

Announced plans to advance FT-104, its novel psychedelic compound, to clinic for Treatment-Resistant Depression and Postpartum Depression as the lead...

FTRP-WT.TO : 0.58 (-10.77%)
FTRP : 3.39 (-0.29%)
FTRP.TO : 4.33 (-1.81%)
MDMA Could be a Massive Game-Changer in the Treatment of PTSD

Post-traumatic stress disorder (PTSDF) affects millions of people. In fact, according to The Recovery ...

FTRP.TO : 4.33 (-1.81%)
CYBN : 1.3800 (-3.50%)
NUMI.VN : 0.580 (-1.69%)
LKYSF : 0.4800 (-3.63%)
MNMD : 1.8850 (-1.31%)
CMPS : 31.04 (-3.00%)
FTRP : 3.39 (-0.29%)
NetworkNewsAudio – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Offers Hope on the Smoking-Cessation Horizon

There isn’t a cigarette smoker in the world who doesn’t know smoking is bad for them. The problems are that nicotine is one of the most highly addictive substances in the world, and for the nearly ...

MYCOF : 0.1520 (+4.83%)
CMPS : 31.04 (-3.00%)
ATAI : 10.97 (+0.46%)
CYBN : 1.3800 (-3.50%)
FTRP : 3.39 (-0.29%)
Field Trip Health Ltd. to Participate in Upcoming Conferences in November 2021

TORONTO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development...

FTRP-WT.TO : 0.58 (-10.77%)
FTRP : 3.39 (-0.29%)
FTRP.TO : 4.33 (-1.81%)
Field Trip Health Ltd. Schedules Second Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, November 16, 2021 at 8:30 AM ET

TORONTO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development...

FTRP-WT.TO : 0.58 (-10.77%)
FTRP : 3.39 (-0.29%)
FTRP.TO : 4.33 (-1.81%)
Breaking the Habit: Psychedelic Stigma Fades as Research Points to Critical Use in Smoking Cessation and More

NetworkNewsWire Editorial Coverage : There isn’t a cigarette smoker in the world who doesn’t know smoking is bad for them. The problems are that nicotine is one of the most highly addictive substances...

MYCOF : 0.1520 (+4.83%)
CMPS : 31.04 (-3.00%)
ATAI : 10.97 (+0.46%)
CYBN : 1.3800 (-3.50%)
FTRP : 3.39 (-0.29%)
Developments with Ketamine Psychotherapy Are Driving A Medical Revolution For Treating Mental Health Issues

Palm Beach, FL –October 28, 2021 – FinancialNewsMedia.com News Commentary  – Psychedelic drugs such as psilocybin, LSD and MDMA have tremendous medical and commercial future potential… and for...

CYBN.NE : 1.780 (-1.66%)
MCUR.CN : 0.250 (-1.96%)
MCURF : 0.1953 (-1.76%)
AWKNF : 2.1730 (-1.23%)
CYBN : 1.3800 (-3.50%)
FTRP : 3.39 (-0.29%)
FTRP.TO : 4.33 (-1.81%)
LKYSF : 0.4800 (-3.63%)
NUMI.VN : 0.580 (-1.69%)
MNMD : 1.8850 (-1.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Field Trip Health Ltd. is involved in the development and delivery of psychedelic therapies. Field Trip Health Ltd. is based in TORONTO.

See More

Key Turning Points

3rd Resistance Point 4.69
2nd Resistance Point 4.40
1st Resistance Point 3.90
Last Price 3.39
1st Support Level 3.11
2nd Support Level 2.82
3rd Support Level 2.32

See More

52-Week High 7.71
Fibonacci 61.8% 5.72
Fibonacci 50% 5.10
Fibonacci 38.2% 4.49
Last Price 3.39
52-Week Low 2.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar